Antibody-drug conjugate having improved stability and use thereof
US10071170B2 · kind B2 · utility
3Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2014 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Jun 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an antibody-drug conjugate comprising a drug conjugated to an antibody, a preparation method thereof and the use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.